Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 5609

1.

Data on the involvement of endothelin-1 (ET-1) in the dysregulation of retinal veins.

Kida T, Flammer J, Oku H, Konieczka K, Morishita S, Horie T, Ikeda T.

Data Brief. 2018 Sep 29;21:59-62. doi: 10.1016/j.dib.2018.09.070. eCollection 2018 Dec.

PMID:
30338274
2.

EFFECTIVENESS OF EN BLOC REMOVAL OF FIBRINOGEN-RICH COMPONENT OF CYSTOID LESION FOR THE TREATMENT OF CYSTOID MACULAR EDEMA.

Imai H, Otsuka K, Tetsumoto A, Miki A, Nakamura M.

Retina. 2018 Oct 16. doi: 10.1097/IAE.0000000000002359. [Epub ahead of print]

PMID:
30334924
3.

Post-marketing safety surveillance and re-evaluation of Xueshuantong injection.

Li C, Xu T, Zhou P, Zhang J, Guan G, Zhang H, Ling X, Li W, Meng F, Liu G, Lv L, Yuan J, Li X, Zhu M.

BMC Complement Altern Med. 2018 Oct 16;18(1):277. doi: 10.1186/s12906-018-2329-z.

4.
5.
6.

Obstructive Sleep Apnea in Neuro-Ophthalmology.

Wong B, Fraser CL.

J Neuroophthalmol. 2018 Oct 8. doi: 10.1097/WNO.0000000000000728. [Epub ahead of print]

PMID:
30300256
7.

Dexamethasone implant (0.7 mg) in Indian patients with macular edema: Real-life scenario.

Nagpal M, Mehrotra N, Juneja R, Jain H.

Taiwan J Ophthalmol. 2018 Jul-Sep;8(3):141-148. doi: 10.4103/tjo.tjo_62_17.

8.

Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion.

Konidaris VE, Tsaousis KT, Anzidei R, de la Mata G, Brent AJ.

Ophthalmol Ther. 2018 Oct 4. doi: 10.1007/s40123-018-0149-3. [Epub ahead of print]

PMID:
30288685
9.

Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.

Babiuch AS, Han M, Conti FF, Wai K, Silva FQ, Singh RP.

JAMA Ophthalmol. 2018 Oct 4. doi: 10.1001/jamaophthalmol.2018.4484. [Epub ahead of print]

PMID:
30286219
10.

Correlation between retinal vein occlusion and cancer - a nationwide Danish cohort study.

Toft-Petersen AP, Muttuvelu DV, Heegaard S, Torp-Pedersen C.

Acta Ophthalmol. 2018 Oct 2. doi: 10.1111/aos.13860. [Epub ahead of print]

PMID:
30280490
11.

Risk of Ischemic Stroke, Hemorrhagic Stroke, and All-Cause Mortality in Retinal Vein Occlusion: A Nationwide Population-Based Cohort Study.

Chen YY, Yen YF, Lin JX, Feng SC, Wei LC, Lai YJ, Shen YC.

J Ophthalmol. 2018 Sep 9;2018:8629429. doi: 10.1155/2018/8629429. eCollection 2018.

12.

Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant.

Niro A, Sborgia G, Sborgia A, Sborgia L, Furino C, Recchimurzo N, Alessio G.

J Ophthalmol. 2018 Sep 9;2018:5604632. doi: 10.1155/2018/5604632. eCollection 2018.

13.

Protective effects of dexamethasone on hypoxia-induced retinal edema in a mouse model.

Inada M, Taguchi M, Harimoto K, Karasawa Y, Takeuchi M, Ito M.

Exp Eye Res. 2018 Sep 26;178:82-90. doi: 10.1016/j.exer.2018.09.014. [Epub ahead of print]

PMID:
30267655
14.

Pathophysiological Role of VEGF on Retinal Edema and Nonperfused Areas in Mouse Eyes With Retinal Vein Occlusion.

Nishinaka A, Inoue Y, Fuma S, Hida Y, Nakamura S, Shimazawa M, Hara H.

Invest Ophthalmol Vis Sci. 2018 Sep 4;59(11):4701-4713. doi: 10.1167/iovs.18-23994.

PMID:
30267092
15.

Intravitreal Bevacizumab (IVB) for Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO).

Azhar MN, Muzaffar W, Arain MA, Farooq O.

J Coll Physicians Surg Pak. 2018 Oct;28(10):758-761. doi: 3016.

PMID:
30266119
16.

Retinal vein thrombosis and risk of occult cancer: A nationwide cohort study.

Hansen AT, Veres K, Prandoni P, Adelborg K, Sørensen HT.

Cancer Med. 2018 Sep 27. doi: 10.1002/cam4.1803. [Epub ahead of print]

17.

Elevation of serum oxidative stress in patients with retina vein occlusions.

Chen KH, Hsiang EL, Hsu MY, Chou YC, Lin TC, Chang YL, Tsai CY, Li TH, Woung LC, Chen SJ, Peng CH, Hwang DK.

Acta Ophthalmol. 2018 Sep 26. doi: 10.1111/aos.13892. [Epub ahead of print]

PMID:
30259675
18.

Cilioretinal artery hypoperfusion and its association with paracentral acute middle maculopathy.

Pichi F, Fragiotta S, Freund KB, Au A, Lembo A, Nucci P, Sebastiani S, Gutierrez Hernandez JC, Interlandi E, Pellegrini F, Dolz-Marco R, Gallego-Pinazo R, Orellana-Rios J, Adatia FA, Munro M, Abboud EB, Ghazi N, Cunha Souza E, Amer R, Neri P, Sarraf D.

Br J Ophthalmol. 2018 Sep 26. pii: bjophthalmol-2018-312774. doi: 10.1136/bjophthalmol-2018-312774. [Epub ahead of print]

PMID:
30257961
19.

A review on recent drug delivery systems for posterior segment of eye.

Nayak K, Misra M.

Biomed Pharmacother. 2018 Nov;107:1564-1582. doi: 10.1016/j.biopha.2018.08.138. Epub 2018 Sep 5. Review.

PMID:
30257375
20.

A meta-analysis of patients with treatment-resistant macular oedema secondary to retinal vein occlusions following switching to aflibercept.

Spooner K, Hong T, Bahrami B, Chang A.

Acta Ophthalmol. 2018 Sep 24. doi: 10.1111/aos.13802. [Epub ahead of print] Review.

PMID:
30251325
21.

Bilateral combined central retinal artery and vein occlusion in a 3-year-old child with nephrotic syndrome.

Sinha S, Rau ATK, Kumar RV, Jayadev C, Vinekar A.

Indian J Ophthalmol. 2018 Oct;66(10):1498-1501. doi: 10.4103/ijo.IJO_1332_17.

22.

Central Retinal Vein Occlusion.

Blair K, Czyz CN.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Aug 24.

23.

Central Retinal Vein Occlusion with Chorioretinal Folds Secondary to Active Thyroid Eye Disease.

Roelofs KA, Eliott D, Freitag SK.

Ophthalmology. 2018 Oct;125(10):1645. doi: 10.1016/j.ophtha.2018.07.001. No abstract available.

PMID:
30243336
24.

Primary angle closure and primary angle closure glaucoma in retinal vein occlusion.

Xu K, Wu L, Ma Z, Liu Y, Qian F.

Acta Ophthalmol. 2018 Sep 21. doi: 10.1111/aos.13879. [Epub ahead of print]

PMID:
30239140
25.

Persistent metamorphopsia associated with branch retinal vein occlusion.

Osaka R, Manabe K, Manabe S, Nakano Y, Takasago Y, Shiragami C, Hirooka K, Muraoka Y, Tsujikawa A.

PLoS One. 2018 Sep 20;13(9):e0204015. doi: 10.1371/journal.pone.0204015. eCollection 2018.

26.

Effect of funding source on reporting bias in studies of intravitreal anti-vascular endothelial growth factor therapy for retinal vein occlusion.

Venincasa MJ, Kuriyan AE, Sridhar J.

Acta Ophthalmol. 2018 Sep 19. doi: 10.1111/aos.13917. [Epub ahead of print]

PMID:
30232841
27.

Application of artificial intelligence in ophthalmology.

Du XL, Li WB, Hu BJ.

Int J Ophthalmol. 2018 Sep 18;11(9):1555-1561. doi: 10.18240/ijo.2018.09.21. eCollection 2018. Review.

28.

Comparison of one and three initial monthly intravitreal ranibizumab injection in patients with macular edema secondary to branch retinal vein occlusion.

Bayat AH, Çakır A, Özturan ŞG, Bölükbaşı S, Erden B, Elçioğlu MN.

Int J Ophthalmol. 2018 Sep 18;11(9):1534-1538. doi: 10.18240/ijo.2018.09.17. eCollection 2018.

29.

Combined cilioretinal artery and hemi-retinal vein occlusion in Sturge Weber syndrome: Expanding the clinical spectrum.

Bakri SS, Jomar D, Alsulaiman SM, Abouammoh MA.

Saudi J Ophthalmol. 2018 Jul-Sep;32(3):234-237. doi: 10.1016/j.sjopt.2017.07.001. Epub 2017 Aug 5.

30.

A review of the multifunctionality of angiopoietin-like 4 in eye disease.

Yang X, Cheng Y, Su G.

Biosci Rep. 2018 Sep 17. pii: BSR20181493. doi: 10.1042/BSR20181493. [Epub ahead of print]

PMID:
30224378
31.

Repeatability of Split-Spectrum Amplitude-Decorrelation Angiography to Assess Capillary Perfusion Density Within Optical Coherence Tomography.

Conti FF, Young JM, Silva FQ, Rodrigues EB, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2018 Sep 1;49(9):e9-e19. doi: 10.3928/23258160-20180907-02.

PMID:
30222814
32.

Secondary Ocular Hypertension and the Risk of Glaucoma Surgery After Dexamethasone Intravitreal Implant in Routine Clinical Practice.

Hemarat K, Kemmer JD, Porco TC, Eaton AM, Khurana RN, Stewart JM.

Ophthalmic Surg Lasers Imaging Retina. 2018 Sep 1;49(9):680-685. doi: 10.3928/23258160-20180831-05.

PMID:
30222802
33.

Ellipsoid Zone Mapping Parameters In Retinal Venous Occlusive Disease With Associated Macular Edema.

Banaee T, Singh RP, Champ K, Conti FF, Wai K, Bena J, Beven L, Ehlers JP.

Ophthalmol Retina. 2018 Aug;2(8):836-841. doi: 10.1016/j.oret.2017.11.009. Epub 2018 Jan 6.

PMID:
30221215
34.

Suspended Scattering Particles in Motion: A Novel Feature of OCT Angiography in Exudative Maculopathies.

Kashani AH, Green KM, Kwon J, Chu Z, Zhang Q, Wang RK, Garrity S, Sarraf D, Rebhun CB, Waheed NK, Schaal KB, Munk MR, Gattoussi S, Freund KB, Zheng F, Liu G, Rosenfeld PJ.

Ophthalmol Retina. 2018 Jul;2(7):694-702. doi: 10.1016/j.oret.2017.11.004. Epub 2017 Dec 15.

PMID:
30221214
35.

[Peripheral Ischemia in Diabetic Retinopathy and Retinal Vein Occlusion: New Insights with Ultra-Wide-Angle Fundus Imaging and Wide-Angle Fluorescein Angiography].

Böker A, Seibel I, Rübsam A, Joussen AM, Zeitz O.

Klin Monbl Augenheilkd. 2018 Sep;235(9):974-979. doi: 10.1055/a-0667-0706. Epub 2018 Sep 14. German.

PMID:
30216951
36.

Revascularization after branch retinal vein occlusion studied by OCT angiography: Report of three cases.

Perálvarez Conde C, Filloy Rius A.

J Fr Ophtalmol. 2018 Oct;41(8):e371-e373. doi: 10.1016/j.jfo.2018.01.008. Epub 2018 Sep 10. No abstract available.

PMID:
30213608
37.

Which quadrant is less painful for intravitreal injection? A prospective study.

Karimi S, Mosavi SA, Jadidi K, Nikkhah H, Kheiri B.

Eye (Lond). 2018 Sep 10. doi: 10.1038/s41433-018-0208-y. [Epub ahead of print]

PMID:
30202072
38.

Retinal vein occlusion and obstructive sleep apnea: a series of 114 patients.

Agard E, El Chehab H, Vie AL, Voirin N, Coste O, Dot C.

Acta Ophthalmol. 2018 Sep 6. doi: 10.1111/aos.13798. [Epub ahead of print]

PMID:
30188014
39.

Bilateral simultaneous central retinal vein occlusion in hyperviscosity retinopathy treated with systemic immunosuppressive therapy only.

Blau-Most M, Gepstein R, Rubowitz A.

Am J Ophthalmol Case Rep. 2018 Aug 29;12:49-51. doi: 10.1016/j.ajoc.2018.08.006. eCollection 2018 Dec.

40.

Causative Pathogens in Endophthalmitis after Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents.

Labardini CP, Blumenthal EZ.

Rambam Maimonides Med J. 2018 Sep 2:1-6. doi: 10.5041/RMMJ.10348. [Epub ahead of print]

PMID:
30180932
41.

Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection.

Güler HA, Örnek N, Örnek K, Büyüktortop Gökçınar N, Oğurel T, Yumuşak ME, Onaran Z.

BMC Ophthalmol. 2018 Sep 4;18(1):235. doi: 10.1186/s12886-018-0905-0.

42.

A Case of Glaucoma in Hereditary Spherocytosis.

Chen H, Symons RCA, Mayson E, Skalicky S.

J Glaucoma. 2018 Aug 31. doi: 10.1097/IJG.0000000000001075. [Epub ahead of print]

PMID:
30180017
43.

Combined Central Retinal Artery and Vein Occlusion From a Presumed Arteriovenous Fistula After Retrobulbar Anesthesia.

Sun V, Chan EW, Eldeeb M, Chen JC.

JAMA Ophthalmol. 2018 Aug 30. doi: 10.1001/jamaophthalmol.2018.3224. [Epub ahead of print] No abstract available.

PMID:
30178027
44.

Evaluation of the Effectiveness of Treatment with Dexamethasone Intravitreal Implant in Cystoid Macular Edema Secondary to Retinal Vein Occlusion.

Donati S, Gandolfi C, Caprani SM, Cattaneo J, Premoli L, Azzolini C.

Biomed Res Int. 2018 Aug 2;2018:3095961. doi: 10.1155/2018/3095961. eCollection 2018.

45.

Central retinal vein occlusion associated with vemurafenib use in metastatic skin melanoma.

Yang SY, Chen SN.

Kaohsiung J Med Sci. 2018 Sep;34(9):535-536. doi: 10.1016/j.kjms.2018.02.005. Epub 2018 Mar 2. No abstract available.

46.

Noninfectious Inflammatory Response following Intravitreal Bevacizumab Injections: Description of a Cluster of Cases in Two Centers and a Review of the Literature.

Trivizki O, Schwartz S, Negri N, Loewenstein A, Rabina G, Shulman S.

Ophthalmologica. 2018;240(3):163-166. doi: 10.1159/000492681. Epub 2018 Aug 31. Review.

PMID:
30173220
47.

[Profile of neovascular glaucoma in Senegalese patients].

Ndiaye-Sow MN, Seck SM, Dieng M, Diakhaté-Diouf M, Agboton GA, Gueye NN.

J Fr Ophtalmol. 2018 Sep;41(7):637-641. doi: 10.1016/j.jfo.2017.11.040. Epub 2018 Aug 27. French.

PMID:
30166236
48.

Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation.

Kawamura M, Hirano Y, Yoshida M, Mizutani T, Sugitani K, Yasukawa T, Ogura Y.

Clin Ophthalmol. 2018 Aug 20;12:1487-1494. doi: 10.2147/OPTH.S170698. eCollection 2018.

49.

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion.

Dogan E, Sever O, Köklü Çakır B, Celik E.

Clin Ophthalmol. 2018 Aug 17;12:1465-1470. doi: 10.2147/OPTH.S162019. eCollection 2018.

50.

Plexus-Specific Detection of Retinal Vascular Pathologic Conditions with Projection-Resolved OCT Angiography.

Patel RC, Wang J, Hwang TS, Zhang M, Gao SS, Pennesi ME, Bailey ST, Lujan BJ, Wang X, Wilson DJ, Huang D, Jia Y.

Ophthalmol Retina. 2018 Aug;2(8):816-826. doi: 10.1016/j.oret.2017.11.010. Epub 2018 Jan 10.

PMID:
30148244

Supplemental Content

Loading ...
Support Center